The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

PRIORITY PRESS - 15th European Cancer Conference and 34th ESMO Multidisciplinary Congress

Towards Extended Survival for Patients with Gliobastoma

Berlin, Germany / September 20-24, 2009

Berlin - Gliomas are the most common type of primary brain tumour in adults and among them, glioblastoma is both the most common and aggressive as discussed here during ECCO-ESMO. A pivotal phase III trial in which chemoradiotherapy...

PRIORITY PRESS - 15th European Cancer Conference and 34th ESMO Multidisciplinary Congress

Optimizing Benefit of TKI Therapy in Metastatic Renal Cell Carcinoma

Berlin, Germany / September 20-24, 2009

Berlin - Tyrosine kinase inhibitor (TKI) therapy remains the reference standard of care for first-line treatment of metastatic renal cell carcinoma. Different dosing regimens of this therapy are currently being explored, as are studies...



July/August 2009

Vaccination against high-risk HPV types to reduce lesions and cervical cancer Moore et al. Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women—implications for vaccination. Cancer Causes Control...

MEDICAL FRONTIERS - XXII Congress of the International Society on Thrombosis and Haemostasis

VTE Treatment and Prophylaxis: Strategies for Improved Intervention

Boston, Massachusetts / July 11-16, 2009

Boston - Thromboprophylaxis is considered a high priority safety intervention in hospitalized patients. In patients with cancer, the incidence and recurrence of venous thromboembolism (VTE) are more common. While several studies have...

MEDICAL FRONTIERS - 64th Annual Meeting of the Canadian Urological Association

Prostate Cancer Risk Reduction with 5-alpha Reductase Inhibitors

Toronto, Ontario / June 28-July 1, 2009

Toronto - Research efforts continue to examine the possible role of risk reduction initiatives in prostate cancer and there have been several important new developments in the field. For example, recent analyses of the initial PCPT...

PRIORITY PRESS - Multinational Association of Supportive Care in Cancer (MASCC)

Emerging Trends and Clinical Advances in CINV Control

Rome, Italy / June 25-27, 2009

Rome - Cancer patients rate nausea and vomiting as among the most distressing side effects of chemotherapy. Despite substantial progress in the control of acute and delayed chemotherapy-induced nausea and vomiting (CINV) since the...

PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the 26th International Congress of Chemotherapy and Infection AMMI Canada/CACMID Annual Conference

Monotherapy or Combination Therapy in Invasive Fungal Infections: A Debate

Toronto, Ontario / June 18-21, 2009

INTRODUCTION A variety of highly effective antifungal agents can now be marshalled against invasive fungal infections and collectively, they are improving outcomes in disseminated disease. Their optimal use is still a matter of debate,...

PRIORITY PRESS - 45th Annual Meeting of the American Society of Clinical Oncology

Reintroducing Chemotherapies in Metastatic Breast Cancer: New Evidence from Clinical Trials

Orlando, Florida / May 29-June 2, 2009

Orlando - In the treatment of breast cancer and other malignancies, there is a reluctance to reintroduce chemotherapies to which patients have been previously exposed. The concerns include diminished efficacy and increased adverse events...

MEDICAL FRONTIERS - 45th Annual Meeting of the American Society of Clinical Oncology

Advanced Hepatocellular and Renal Cell Carcinomas: Assessment of Survival Benefits with Targeted Therapies

Orlando, Florida / May 29-June 2, 2009

Orlando - In separate sets of studies, small-molecule multikinase inhibitors have altered the clinical course of advanced hepatocellular carcinoma (HCC) and advanced renal cell carcinoma (RCC). Meaningful improvements in outcome in each...

PAGE 10 OF 23   1 2 3 4 5 6 7 8 9 10 ...